ATE520670T1 - Pyridazinderivate - Google Patents
PyridazinderivateInfo
- Publication number
- ATE520670T1 ATE520670T1 AT06777461T AT06777461T ATE520670T1 AT E520670 T1 ATE520670 T1 AT E520670T1 AT 06777461 T AT06777461 T AT 06777461T AT 06777461 T AT06777461 T AT 06777461T AT E520670 T1 ATE520670 T1 AT E520670T1
- Authority
- AT
- Austria
- Prior art keywords
- pyridazine derivatives
- pyridazine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/28—Cinnolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05106098 | 2005-07-05 | ||
| PCT/EP2006/063533 WO2007003521A2 (en) | 2005-07-05 | 2006-06-26 | Pyridazine derivatives as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE520670T1 true ATE520670T1 (de) | 2011-09-15 |
Family
ID=36781523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06777461T ATE520670T1 (de) | 2005-07-05 | 2006-06-26 | Pyridazinderivate |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US7678795B2 (de) |
| EP (1) | EP1904455B1 (de) |
| JP (1) | JP4787321B2 (de) |
| KR (1) | KR100979582B1 (de) |
| CN (1) | CN101528713B (de) |
| AR (1) | AR054814A1 (de) |
| AT (1) | ATE520670T1 (de) |
| AU (1) | AU2006265201C1 (de) |
| BR (1) | BRPI0613565A2 (de) |
| CA (1) | CA2612740C (de) |
| CL (1) | CL2009001936A1 (de) |
| CR (1) | CR9587A (de) |
| CY (1) | CY1112401T1 (de) |
| DK (1) | DK1904455T3 (de) |
| EC (1) | ECSP088082A (de) |
| ES (1) | ES2370039T3 (de) |
| HK (1) | HK1134087A1 (de) |
| HR (1) | HRP20110808T1 (de) |
| IL (1) | IL188182A (de) |
| MA (1) | MA29909B1 (de) |
| MX (1) | MX2007016352A (de) |
| MY (1) | MY144209A (de) |
| NO (1) | NO20076431L (de) |
| NZ (1) | NZ564260A (de) |
| PL (1) | PL1904455T3 (de) |
| PT (1) | PT1904455E (de) |
| RS (1) | RS51994B (de) |
| RU (1) | RU2401832C2 (de) |
| SI (1) | SI1904455T1 (de) |
| TW (1) | TWI323258B (de) |
| UA (1) | UA94052C2 (de) |
| WO (1) | WO2007003521A2 (de) |
| ZA (1) | ZA200710972B (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7834178B2 (en) | 2006-03-01 | 2010-11-16 | Bristol-Myers Squibb Company | Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| RU2009108280A (ru) | 2006-08-08 | 2010-09-20 | Санофи-Авентис (Fr) | Ариламиноарилалкилзамещенные имидазолидин-2,4-дионы, способы их получения, содержащие эти соединения лекарственные средства и их применение |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| WO2009131947A2 (en) * | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, compositions and methods comprising pyridazine derivatives |
| WO2009131958A2 (en) * | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, compositions and methods comprising triazine derivatives |
| WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| US8501940B2 (en) * | 2008-07-15 | 2013-08-06 | Hoffmann-La Roche Inc. | Tetrahydrocinnoline derivatives |
| US20100022572A1 (en) | 2008-07-18 | 2010-01-28 | Kowa Company, Ltd. | Novel spiro compound and medicine comprising the same |
| WO2010023931A1 (ja) | 2008-08-29 | 2010-03-04 | 興和株式会社 | １－アダマンチルアゼチジン－２－オン誘導体及びこれを含有する医薬 |
| JP5477973B2 (ja) | 2008-10-29 | 2014-04-23 | 興和株式会社 | １，２−ジアゼチジン−３−オン誘導体及びこれを含有する医薬 |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| US20100267706A1 (en) * | 2009-04-20 | 2010-10-21 | Institute For Oneworld Health | Compounds, Compositions and Methods Comprising Pyridazine Derivatives |
| ES2350077B1 (es) | 2009-06-04 | 2011-11-04 | Laboratorios Salvat, S.A. | Compuestos inhibidores de 11beta-hidroxiesteroide deshidrogenasa de tipo 1. |
| WO2011023754A1 (en) | 2009-08-26 | 2011-03-03 | Sanofi-Aventis | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (de) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamidderivate als kinaseinhibitoren |
| CN105705492B (zh) * | 2013-11-05 | 2019-11-05 | 豪夫迈·罗氏有限公司 | 作为rorc调节剂用于治疗自身免疫性疾病的5,6,7,8-四氢-5,8-亚甲基噌啉衍生物 |
| EP3235813A1 (de) | 2016-04-19 | 2017-10-25 | Cidqo 2012, S.L. | Aza-tetra-cyclo-derivate |
| BR112019008821A8 (pt) * | 2016-11-01 | 2020-02-04 | Hoffmann La Roche | derivados de piridazina como moduladores de rorc |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4607458B2 (ja) * | 2002-02-05 | 2011-01-05 | ハイ・ポイント・ファーマスーティカルズ、エルエルシー | 新規なアリールおよびへテロアリールピペラジン |
| TWI314455B (en) * | 2002-12-10 | 2009-09-11 | Nippon Kayaku Kk | 3-phenyl-cinnoline derivatives and anti-tumor agent containing the same |
| TW200503994A (en) | 2003-01-24 | 2005-02-01 | Novartis Ag | Organic compounds |
| EP1615647B1 (de) | 2003-04-11 | 2010-01-20 | High Point Pharmaceuticals, LLC | Pharmazeutische verwendungen von kondensierten 1,2,4-triazolen |
-
2006
- 2006-06-26 SI SI200631140T patent/SI1904455T1/sl unknown
- 2006-06-26 UA UAA200801149A patent/UA94052C2/uk unknown
- 2006-06-26 PT PT06777461T patent/PT1904455E/pt unknown
- 2006-06-26 KR KR1020087000144A patent/KR100979582B1/ko not_active IP Right Cessation
- 2006-06-26 JP JP2008519896A patent/JP4787321B2/ja not_active Expired - Fee Related
- 2006-06-26 NZ NZ564260A patent/NZ564260A/en not_active IP Right Cessation
- 2006-06-26 DK DK06777461.2T patent/DK1904455T3/da active
- 2006-06-26 BR BRPI0613565-0A patent/BRPI0613565A2/pt not_active IP Right Cessation
- 2006-06-26 RS RS20110396A patent/RS51994B/en unknown
- 2006-06-26 EP EP06777461A patent/EP1904455B1/de active Active
- 2006-06-26 AT AT06777461T patent/ATE520670T1/de active
- 2006-06-26 WO PCT/EP2006/063533 patent/WO2007003521A2/en active Application Filing
- 2006-06-26 PL PL06777461T patent/PL1904455T3/pl unknown
- 2006-06-26 CA CA2612740A patent/CA2612740C/en not_active Expired - Fee Related
- 2006-06-26 ES ES06777461T patent/ES2370039T3/es active Active
- 2006-06-26 RU RU2008103483/04A patent/RU2401832C2/ru not_active IP Right Cessation
- 2006-06-26 MX MX2007016352A patent/MX2007016352A/es active IP Right Grant
- 2006-06-26 AU AU2006265201A patent/AU2006265201C1/en not_active Ceased
- 2006-06-26 CN CN200680023527XA patent/CN101528713B/zh not_active Expired - Fee Related
- 2006-07-03 AR ARP060102856A patent/AR054814A1/es not_active Application Discontinuation
- 2006-07-03 MY MYPI20063158A patent/MY144209A/en unknown
- 2006-07-03 TW TW095124178A patent/TWI323258B/zh active
- 2006-07-05 US US11/481,330 patent/US7678795B2/en not_active Expired - Fee Related
-
2007
- 2007-12-11 CR CR9587A patent/CR9587A/es unknown
- 2007-12-14 NO NO20076431A patent/NO20076431L/no not_active Application Discontinuation
- 2007-12-17 IL IL188182A patent/IL188182A/en not_active IP Right Cessation
- 2007-12-18 ZA ZA200710972A patent/ZA200710972B/xx unknown
-
2008
- 2008-01-04 EC EC2008008082A patent/ECSP088082A/es unknown
- 2008-01-04 MA MA30542A patent/MA29909B1/fr unknown
-
2009
- 2009-10-06 CL CL2009001936A patent/CL2009001936A1/es unknown
-
2010
- 2010-02-25 HK HK10101976.4A patent/HK1134087A1/xx not_active IP Right Cessation
-
2011
- 2011-09-28 CY CY20111100942T patent/CY1112401T1/el unknown
- 2011-11-02 HR HR20110808T patent/HRP20110808T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE520670T1 (de) | Pyridazinderivate | |
| ATE408603T1 (de) | Pyrazolylcarboxanilide | |
| NO20062260L (no) | Bronnforbindelsessystem | |
| CR9974A (es) | Gavión | |
| DE502006003394D1 (de) | Lehnenklappung | |
| DE602006010581D1 (de) | 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate | |
| DE502006008475D1 (de) | Wasserpumpenflügelrad | |
| ATE485294T1 (de) | Azaindol-2-carboxamid-derivate | |
| DE502006005667D1 (de) | Gelenklager | |
| ATE549324T1 (de) | Tetrahydrobenzoxazine | |
| ATE527255T1 (de) | Aryl-isoxazol-4-yl-imidazol-derivate | |
| DK1971588T3 (da) | Tiglien-3-onderivater | |
| DE502006005768D1 (de) | Hydrolysestabilisatorformulierungen | |
| DE502006006857D1 (de) | Wingungserregern | |
| DE112006002964A5 (de) | Zweirichtungsreflektanzverteilungsmessgerät | |
| DE502005005839D1 (de) | Feldgeerät | |
| DE602006014973D1 (de) | Neuartige cercosporamidderivate | |
| DE502006001397D1 (de) | Lagerbuchse | |
| ATE485368T1 (de) | Hiv - impfung | |
| DE502006004302D1 (de) | Verschlusskappe | |
| DE502006001004D1 (de) | Hydrolager | |
| ATE541837T1 (de) | Oxaphenanthren-derivate | |
| DE502006003210D1 (de) | Nohydrogenpolysiloxanen | |
| AT501523A3 (de) | Estrich | |
| DE102006033170A8 (de) | Einfassnähmaschine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1904455 Country of ref document: EP |